The names Tom Kennedy and Emma Walmsley represent two very different paths to leadership at major global companies. Tom Kennedy and Emma Walmsley Kennedy is best known for his long career at Raytheon, where he progressed from engineering and technical positions to become chairman and chief executive officer. Emma Walmsley, meanwhile, built her early career in consumer products at L’Oréal before moving into healthcare leadership and eventually becoming CEO of GSK.
Although the two executives worked in very different industries, their careers share an interesting theme: both reached the highest levels of corporate leadership after developing expertise in complex international organizations. Kennedy’s background was rooted in engineering, aerospace, and defense technology, while Walmsley’s experience was shaped by marketing, consumer businesses, healthcare, and corporate strategy.
There is no widely documented personal or direct business partnership between Tom Kennedy and Emma Walmsley Kennedy and Emma Walmsley. Instead, searches for Tom Kennedy and Emma Walmsley are more useful when viewed as a comparison of two senior executives who followed very different routes to the top. Their stories provide an interesting look at how technical knowledge, commercial experience, strategic thinking, and leadership can shape a major executive career.
Who Is Tom Kennedy?
Thomas A. Kennedy, commonly known as Tom Kennedy and Emma Walmsley Kennedy, is an American engineer and business executive who spent more than three decades with Raytheon. He joined the company in 1983 after serving as a captain in the U.S. Air Force. Over the years, he held a series of increasingly senior positions involving radar, electronic warfare, defense systems, and business operations.
Kennedy’s educational background was strongly technical. He earned a bachelor’s degree in electrical engineering from Rutgers University, a master’s degree from the Air Force Institute of Technology, and a doctorate in engineering from the University of California, Los Angeles. This combination of military and engineering experience became an important part of his professional identity.
His rise at Raytheon was gradual rather than sudden. He moved through engineering, program, operational, and business leadership positions before becoming executive vice president and chief operating officer. In 2014, Raytheon appointed him CEO, succeeding William H. Swanson. He later also became chairman of the company.
Tom Kennedy’s Career at Raytheon
Kennedy joined Raytheon at a time when the company was deeply involved in advanced defense and electronic technologies. During his career, he worked across areas involving radar, airborne systems, electronic warfare, sensors, and defense integration.
Before becoming CEO, Kennedy served as president of Raytheon’s Integrated Defense Systems business. He also held leadership responsibilities within the company’s Space and Airborne Systems organization. These positions gave him experience with both the technical side of the business and the broader commercial and operational decisions required to run large divisions.
In 2013, Kennedy became Raytheon’s executive vice president and chief operating officer. One of the major responsibilities associated with that period was the consolidation of Raytheon’s six businesses into four. The company said the restructuring was intended to improve productivity, agility, and affordability.
Kennedy became chief executive officer on March 31, 2014. His promotion was significant because he had spent decades inside the company and understood its technology, customers, employees, and operating structure. His career demonstrates how technical expertise can develop into broader corporate leadership over time.
Tom Kennedy and the Raytheon-United Technologies Merger
One of the most important events connected to Tom Kennedy and Emma Walmsley Kennedy’s later career was the combination of Raytheon and United Technologies.
The transaction was completed on April 3, 2020, creating Raytheon Technologies. The newly formed company combined major aerospace and defense businesses and began trading under the ticker RTX. Kennedy became executive chairman, while Greg Hayes served as CEO.
The merger represented a major change for both organizations. The resulting company brought together businesses serving commercial aerospace, military, and government customers. According to the company’s announcement at the time, the combined organization had approximately $74 billion in pro forma 2019 net sales and around 195,000 employees.
Kennedy’s role changed after the merger. Rather than continuing as CEO of the original Raytheon Company, he became executive chairman of the newly created corporation. This transition illustrates how senior executives sometimes change responsibilities when companies combine and governance structures are redesigned.
Kennedy retired as executive chairman in June 2021. Textron later announced that he had been elected to its board of directors, effective January 1, 2023.
Who Is Emma Walmsley?
Emma Walmsley is a British business executive who became widely known for her leadership of GSK. Before joining the pharmaceutical industry, she spent 17 years at L’Oréal, where she held marketing and general management positions in the UK, Europe, and the United States.
Her international experience became particularly important during her time in China. From 2007, Walmsley was based in Shanghai as general manager of L’Oréal China Consumer Products. That role gave her substantial experience in international consumer markets before she moved into healthcare.
Walmsley joined GSK in 2010. She initially worked in the company’s consumer healthcare division and eventually became CEO of GSK Consumer Healthcare. GSK announced in 2016 that she would succeed Andrew Witty as group CEO, and she formally took over the position in April 2017.
Her appointment attracted considerable attention because her career had primarily been in consumer products and marketing rather than pharmaceutical research. Nevertheless, her experience managing large international businesses became a major part of her leadership approach at GSK.
Emma Walmsley’s Career at GSK
Walmsley’s time at GSK involved a significant transformation of the company.
When she became CEO in 2017, GSK was a broad healthcare organization with operations spanning pharmaceuticals, vaccines, and consumer healthcare. Over the following years, the company increasingly focused its strategy on biopharmaceuticals, vaccines, and specialty medicines.
One of the defining events of her tenure was the separation of GSK’s consumer healthcare business. The consumer-health operation eventually became Haleon, an independently listed company. The separation allowed GSK to concentrate more heavily on pharmaceuticals and vaccines while giving the consumer-health business its own corporate identity.
Walmsley’s leadership also involved major decisions about research and development, acquisitions, portfolio management, and investment. Pharmaceutical companies operate in an environment where research programs can take years and where regulatory approval is essential, so corporate strategy must account for considerable scientific and financial uncertainty.
Emma Walmsley and the Creation of Haleon
The creation of Haleon was one of the clearest structural changes associated with Walmsley’s GSK leadership.
Consumer healthcare had been an important part of GSK for many years. However, separating that business allowed the remaining GSK organization to focus more directly on biopharmaceutical research, vaccines, and specialty medicines.
The move also reflected a broader strategic question faced by large corporations: should different businesses remain together under one corporate structure, or can they operate more effectively as separate companies?
In GSK’s case, the consumer healthcare business became Haleon. The separation changed the identity of both organizations and represented one of the most important corporate transformations during Walmsley’s time as CEO.
For Walmsley personally, the change was notable because consumer healthcare had been a major part of her own career at GSK. She had previously led the consumer-healthcare business before becoming group CEO.
Emma Walmsley’s Leadership Style and Background
Walmsley’s career is interesting because she did not follow the traditional route of becoming a pharmaceutical CEO through medical or laboratory research.
Her academic background was in classics and modern languages at Oxford, while her early professional experience came from marketing and general management. Rather than being a scientist herself, she developed experience in managing people, brands, international operations, and large businesses.
That background influenced how her career developed at GSK. Her experience in consumer healthcare gave her familiarity with health-related products and international markets before she took responsibility for the entire company.
Her leadership also demonstrated that the CEO of a science-driven organization does not necessarily have to be the company’s leading scientist. A chief executive can instead be responsible for strategy, capital allocation, organizational decisions, talent, governance, and creating the environment in which scientific teams can perform their work.
Walmsley’s career is therefore a useful example of how commercial leadership skills can transfer into a highly regulated and science-focused industry.
Tom Kennedy and Emma Walmsley: Comparing Their Careers
When comparing Tom Kennedy and Emma Walmsley, the biggest difference is their professional starting point.
Kennedy began with engineering and military experience. His career developed around technology, radar, defense systems, and aerospace. Walmsley began with consumer products, marketing, and international business management before moving into healthcare.
Their educational backgrounds were also different. Kennedy pursued electrical engineering and advanced engineering education, while Walmsley studied classics and modern languages at Oxford.
Despite these differences, both careers show the importance of learning an organization from the inside. Kennedy spent decades at Raytheon before becoming CEO. Walmsley spent several years at GSK, first leading its consumer-healthcare operation, before becoming group CEO.
Both also eventually became responsible for major organizational change. Kennedy was involved in the transformation that followed the combination of Raytheon and United Technologies. Walmsley oversaw the transformation that separated GSK’s consumer-healthcare business into Haleon.
Technical Expertise Versus Commercial Experience
The careers of Kennedy and Walmsley also raise an interesting question about what type of experience prepares someone to become a CEO.
Kennedy’s career provides an example of technical expertise evolving into corporate leadership. He understood many of the technologies and systems connected to Raytheon’s business before taking responsibility for the entire company.
Walmsley’s career demonstrates another route. Her strength was rooted in commercial management, international markets, branding, and organizational leadership. She later applied those skills to a pharmaceutical company with highly specialized scientific teams.
Neither approach is automatically the same as the other. A technology company may benefit from a leader with deep engineering knowledge, while another organization may need a leader whose strengths are strategy, commercial management, organizational change, or international operations.
The two careers show that large companies can require different combinations of expertise depending on their industries, structures, and strategic challenges.
What Happened to Tom Kennedy After Raytheon?
Tom Kennedy and Emma Walmsley Kennedy retired as executive chairman of Raytheon Technologies in June 2021. His retirement came after a long career that began when he joined Raytheon in 1983.
His professional experience did not end with retirement from Raytheon Technologies. In 2022, Textron announced that Kennedy would join its board of directors beginning in January 2023. He has also been listed in corporate governance roles connected with Fidelity funds.
His later career reflects a common path for former CEOs of large corporations. Instead of running a company day to day, experienced executives can contribute through board service, governance, strategic oversight, and industry knowledge.
Kennedy’s continued involvement in aerospace and defense-related corporate governance also connects with the industry in which he spent most of his professional life.
What Happened to Emma Walmsley After GSK?
Emma Walmsley’s tenure as GSK CEO ended on December 31, 2025. Luke Miels became GSK’s CEO on January 1, 2026.
GSK had announced the leadership transition in 2025. Walmsley stepped down from the company’s board at the end of 2025, while the company said she would remain available through September 30, 2026 to support the transition and provide advice on areas including geopolitics and emerging technologies.
This means that current articles should not describe Walmsley as GSK’s current CEO in 2026. She is a former GSK CEO following nearly nine years in the role.
Her career at GSK remains significant because she oversaw major strategic and structural changes, including the separation of consumer healthcare into Haleon.
Is There a Relationship Between Tom Kennedy and Emma Walmsley?
A common question surrounding the keyword Tom Kennedy and Emma Walmsley is whether the two executives have a personal or professional relationship.
Available public information does not establish a prominent partnership between them. Kennedy’s career was centered on Raytheon and the aerospace and defense industry, while Walmsley’s best-known corporate career was at L’Oréal and GSK.
Their names can therefore be discussed together as part of a broader comparison of executive careers rather than as evidence of a shared company, family connection, or business partnership.
It is important to avoid assuming a relationship simply because two public figures appear together in an online search. Similar search results can occur because databases, business articles, biographies, and search engines place unrelated executives on the same pages.
Frequently Asked Questions About Tom Kennedy and Emma Walmsley
Who is Tom Kennedy?
Tom Kennedy and Emma Walmsley Kennedy, formally Thomas A. Kennedy, is an American engineer and former Raytheon chairman and CEO. He joined Raytheon in 1983 and held numerous technical and executive positions before becoming CEO in 2014. He later served as executive chairman of Raytheon Technologies after the 2020 combination with United Technologies.
Who is Emma Walmsley?
Emma Walmsley is a British business executive and former GSK CEO. She previously spent 17 years at L’Oréal and joined GSK in 2010. She became GSK’s group CEO in April 2017 and remained in the position through December 2025.
Did Tom Kennedy and Emma Walmsley work together?
There is no prominent public record establishing that Kennedy and Walmsley worked together in a major executive role. Kennedy’s career was primarily connected with Raytheon and aerospace and defense, while Walmsley’s major leadership career was associated with L’Oréal and GSK.
What is Tom Kennedy known for?
Tom Kennedy and Emma Walmsley Kennedy is best known for serving as chairman and CEO of Raytheon and later as executive chairman of Raytheon Technologies. He is also known for his engineering background and long career in defense technology.
What is Emma Walmsley known for?
Emma Walmsley is best known for leading GSK from 2017 through 2025 and overseeing major strategic changes, including the separation of the company’s consumer-healthcare business into Haleon.
What industries did they work in?
Kennedy spent most of his career in aerospace and defense technology. Walmsley worked across consumer products and pharmaceuticals, with major experience at L’Oréal and GSK.
Did Emma Walmsley study medicine?
No. Walmsley studied classics and modern languages at Oxford. Her professional career developed through marketing, general management, consumer healthcare, and corporate leadership rather than medical training.
Did Tom Kennedy have an engineering background?
Yes. Kennedy earned degrees in electrical engineering and a doctorate in engineering. His early professional career also included military and technical work before he moved into senior Raytheon leadership.
Final Thoughts on Tom Kennedy and Emma Walmsley
The story behind Tom Kennedy and Emma Walmsley is ultimately a comparison between two very different executive journeys.
Kennedy built his reputation through engineering, defense technology, operational leadership, and decades of experience at Raytheon. His career eventually took him to the CEO and chairman positions and later to the executive chairmanship of Raytheon Technologies following its combination with United Technologies.
Walmsley followed a different route. Her career began in consumer products at L’Oréal before she moved to GSK, where she rose through consumer healthcare leadership and eventually became group CEO. Her tenure included a major restructuring of GSK and the separation of consumer healthcare into Haleon.
Neither career follows exactly the same formula, and that is what makes the comparison interesting. Kennedy illustrates how technical expertise can develop into large-scale corporate leadership, while Walmsley demonstrates how commercial and international management experience can transfer into a highly specialized healthcare organization.
For readers searching for Tom Kennedy and Emma Walmsley, the most useful takeaway is not that the two executives are closely connected, but that their careers offer two distinct examples of modern corporate leadership. Their different educational backgrounds, industries, and strategic responsibilities provide a useful way to understand how executives can reach the top of major global organizations through very different professional paths.
You May Also Read: Jeannine Belleguic
